TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026

A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903).

Yasuyuki Kawamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.